Thyroid Disorder Market Revenue Trends, Company Profiles, Revenue Share Analysis, 2027
Booming economies across the world is experiencing a radical
shift to urbanization which, in a supple way, is creating a physiological
disorder that is giving rise to the prevalence of various ailments. Diseases
such as obesity, thyroid, autoimmune diseases are a common byproduct of this
shift and trigger thyroid disorders in many which, if not checked, in time can
cause severe brain damage. With the expected CAGR of 3.60%, the global thyroid
disorder market is also likely to touch a 3,241.21 million USD mark during
the forecast period, The rising cases of thyroid disorder have become a concern
for many initiating a collaborative agreement between private and public
organizations to spread awareness. Efforts made by the pharmacies can be
considered a tactical gambit in this context. As per the report of the
International Thyroid Society, near about 20 million Americans are diagnosed
with some form of thyroid disease, and around 12% can get affected by it in
their lifetime. Chances of contracting the disease can aggravate if the patient
has diabetes.
However, the treatment incurs high cost, and alternative
treatment options are on the rise which can act as a headwind for the market.
Side-effects of the treatment cannot be blind sighted as well. In considering
the future of the market, this can seriously cause a plummeting effect.
Industry Trend:
New research by the University of Colorado School of
Medicine Department of Radiation Oncology has revealed that thyroid tumors can
be treated with stereotactic body radiation therapy (SBRT). The side-effects
would be far lesser than the traditional method and the treatment promises the
better chance of recovery. The University of Birmingham has recently called for
universal testing for thyroid function to reduce the number of miscarriages and
negative neurodevelopmental effects on the baby.
Segmentation:
The global thyroid disorder market can be segmented by
treatment, disease indication, route of administration and end-users.
By thyroid
problems treatments , the market is segmented into drugs & supplements,
diagnostics, and surgery.
Based on disease indication, the market includes
hypothyroidism, hyperthyroidism, and others. The hypothyroidism holds the
largest market share.
Based on the route of administration, the market encompasses
oral, injectable, and others. High efficacy and bioavailability made the oral
segment the most preferable.
On the basis of end-users, the market comprises hospitals
and home use.
Regional Analysis:
Region-specific segmentation includes the Americas, Europe,
Asia Pacific (APAC), and the Middle East & Africa.
The Americas are currently leading the pack with the maximum
share of the market. North America is spearheading the region with a
considerable number of patients and advanced technologies used in treating the
disease in multiple facilities. Europe assumes the second position. However,
the APAC is set to register the maximum CAGR during the forecast period as the
region has two countries such as China and India which are showing considerable
expansion. Market incumbents are also launching strategies to raise awareness
among the populace which can further boost the sector’s revenue.
Market Competition:
The presence of several big shots across the globe is
promising for the market as this will keep the market competitive and help it
gain much from research and developments.
Some of the key players in this market are namely Allergan
(Ireland), Abbott Laboratories (US), GlaxoSmithKline Plc (UK), Merck & Co.,
Inc. (US), Pfizer Inc. (US), RLC LABS (US), AbbVie (US), Mylan (US)and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312

Comments
Post a Comment